Get started
Klotho Neurosciences, Inc.Klotho Neurosciences, Inc.Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc.

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

KLTO fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
KLTO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company